Viewing PDF documents requires Adobe Acrobat Reader, which may be downloaded for free.
December 16, 2008 Response Biomedical Announces Change of Executives Newswire.caPDF
December 2, 2008 Response Biomedical Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial Newswire.caPDF
November 13, 2008 Response Biomedical Announces Third Quarter Results Newswire.caPDF
November 4, 2008 Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference Newswire.caPDF
October 31, 2008 Response Biomedical Closes $5.1 Million Financing Newswire.caPDF
October 30, 2008 Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference Newswire.caPDF
October 28, 2008 Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing Newswire.caPDF
October 24, 2008 Response Biomedical Announces Insider Participation in Current Financing Newswire.caPDF
October 17, 2008 Response Biomedical Announces $5.5 Million Financing Terms Amended Newswire.caPDF
October 14, 2008 Response Biomedical Announces $5.5 Million Financing Newswire.caPDF
August 14, 2008 Response Biomedical Corporation Announces Second Quarter Results Newswire.caPDF
July 22, 2008 Response Biomedical Receives US FDA Clearance for RAMP® NT-proBNP Test for Diagnosis of Heart Failure Newswire.caPDF
June 26, 2008 Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests Newswire.caPDF
May 16, 2008 Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Newswire.caPDF
May 15, 2008 Response Biomedical Corporation Announces First Quarter Results Newswire.caPDF
April 17, 2008 Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test Newswire.caPDF